首页> 外文OA文献 >Comparable outcomes for β-lactam/β-lactamase inhibitor combinations and carbapenems in definitive treatment of bloodstream infections caused by cefotaxime-resistant Escherichia coli or Klebsiella pneumoniae

【2h】

Comparable outcomes for β-lactam/β-lactamase inhibitor combinations and carbapenems in definitive treatment of bloodstream infections caused by cefotaxime-resistant Escherichia coli or Klebsiella pneumoniae

机译：β-内酰胺/β-内酰胺酶抑制剂组合和碳青霉烯类药物在抗头孢噻肟耐药的大肠杆菌或肺炎克雷伯菌引起的血流感染的最终治疗中具有可比的结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Patrick N A Harris; Mo Yin; Roland Jureen; Jonathan Chew; Jaminah Ali; Stuart Paynter; David L Paterson; Paul A Tambyah;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Comparable outcomes for β-lactam/β-lactamase inhibitor combinations and carbapenems in definitive treatment of bloodstream infections caused by cefotaxime-resistant Escherichia coli or Klebsiella pneumoniae [J] . Patrick N A Harris, Mo Yin, Roland Jureen, Antimicrobial Resistance and Infection Control . 2015,第1期

机译：β-内酰胺/β-内酰胺酶抑制剂组合和碳青霉烯类药物在耐头孢噻肟耐药的大肠杆菌或肺炎克雷伯菌引起的血流感染的最终治疗中具有可比的结果
2. Comparison of therapy with β-lactam/β-lactamase inhibitor combinations or carbapenems for bacteraemia of nonurinary source caused by ESBL-producing Escherichia coli or Klebsiella pneumoniae [J] . Luo Hong, Xiao Yanping, Hang Yaping, Annals of Clinical Microbiology and Antimicrobials . 2021,第1期

机译：β-内酰胺/β-乳酰胺酶抑制剂组合或碳癌患者对由ESBL的大肠杆菌或Klebsiella肺炎引起的非源性菌血症的β-内酰胺/β-乳酰胺酶抑制剂组合的比较或Carbapems
3. Bloodstream Infections Due to Extended-Spectrum {beta}-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae: Risk Factors for Mortality and Treatment Outcome, with Special Emphasis on Antimicrobial Therapy. [J] . Choe KW Antimicrobial agents and chemotherapy. . 2004,第12期

机译：由于产生广谱β-内酰胺酶的大肠杆菌和肺炎克雷伯菌引起的血流感染：死亡率和治疗结果的危险因素，特别强调了抗微生物治疗。
4. Antimicrobial treatment of experimental infection due to an extended-spectrum β-lactamase-producing Klebsiella pneumoniae strain [D] . Mathe, Andras 2007

机译：产生大范围β-内酰胺酶的肺炎克雷伯氏菌菌株对实验性感染的抗菌治疗
5. Comparable outcomes for β-lactam/β-lactamase inhibitor combinations and carbapenems in definitive treatment of bloodstream infections caused by cefotaxime-resistant Escherichia coli or Klebsiella pneumoniae [O] . Patrick N A Harris, Mo Yin, Roland Jureen, 2015

机译：β-内酰胺/β-内酰胺酶抑制剂组合和碳青霉烯类药物在耐头孢噻肟耐药大肠埃希菌或肺炎克雷伯菌引起的血流感染的最终治疗中具有可比的结果
6. 1041. How Do Healthcare Providers Approach Empiric β-Lactam (BL) Treatment of Bloodstream Infections (BSI) Caused by Gram-Negative Rods (GNRs)? Analysis of Escherichia coli and Klebsiella pneumoniae BSI From the Veterans Health Administration (VHA) [O] . Roberto Viau, Brigid Wilson, Scott R Evans, 2018

机译：1041.医疗保健提供者如何接近由革兰氏阴性杆（GNR）引起的血流感染（BSI）的仿真β-内酰胺（BL）处理？退伍军人健康管理局（VHA）的大肠杆菌和Klebsiella Pneumoniae BSI分析

Comparable outcomes for β-lactam/β-lactamase inhibitor combinations and carbapenems in definitive treatment of bloodstream infections caused by cefotaxime-resistant Escherichia coli or Klebsiella pneumoniae

著录项

引文网络

相似文献

相关主题

期刊订阅